Marchés français ouverture 35 min

Sysmex Corporation (SSMXF)

Other OTC - Other OTC Prix différé. Devise en USD
Ajouter à la liste dynamique
58,960,00 (0,00 %)
À la clôture : 02:32PM EST

Sysmex Corporation

1-5-1 Wakinohama-kaigandori
Chuo-ku
Kobe 651-0073
Japan
81 78 265 0500
https://www.sysmex.co.jp

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein9 500

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Hisashi IetsuguChairman of the Managing Board & Group CEO1,52MS.O.1949
Mr. Kaoru AsanoPresident & Representative DirectorS.O.S.O.1958
Mr. Chris CappellaChief Financial OfficerS.O.S.O.S.O.
Mr. Tomokazu YoshidaManaging Executive Officer, CTO & Member of the Managing BoardS.O.S.O.1964
Mr. Frank BuescherSenior Executive OfficerS.O.S.O.S.O.
Mr. Iwane MatsuiSenior Managing Executive Officer & Member of the Managing BoardS.O.S.O.1961
Mr. Kenji TachibanaSr. MD of Corp Mgmt & Regulatory Affairs, Sr. Exec. Officer & Member of the Managing BoardS.O.S.O.1957
Mr. Mamoru KubotaSenior Executive OfficerS.O.S.O.S.O.
Mr. Kensuke IizukaSenior Executive Officer & Executive VP of Corporate Business Planning Div.S.O.S.O.S.O.
Mr. Zuo Hui PengExecutive OfficerS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Sysmex Corporation en date du 1 février 2024 est 4. Les scores principaux sont Audit : 1; Société : 6; Droits des actionnaires : 4; Compensation : 1.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.